These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 25744005)

  • 1. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    Gonzalez Corcia MC; Sieira J; Pappaert G; de Asmundis C; Chierchia GB; La Meir M; Sarkozy A; Brugada P
    J Am Coll Cardiol; 2018 Jan; 71(2):148-157. PubMed ID: 29325638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced brugada syndrome in children: clinical features, device-based management, and long-term follow-up.
    Conte G; Dewals W; Sieira J; de Asmundis C; Ciconte G; Chierchia GB; Di Giovanni G; Baltogiannis G; Saitoh Y; Levinstein M; La Meir M; Wellens F; Pappaert G; Brugada P
    J Am Coll Cardiol; 2014 Jun; 63(21):2272-9. PubMed ID: 24681144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator.
    Dores H; Reis Santos K; Adragão P; Moscoso Costa F; Galvão Santos P; Carmo P; Cavaco D; Bello Morgado F; Mendes M
    Rev Port Cardiol; 2015 Jun; 34(6):395-402. PubMed ID: 26028488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
    Sarkozy A; Boussy T; Kourgiannides G; Chierchia GB; Richter S; De Potter T; Geelen P; Wellens F; Spreeuwenberg MD; Brugada P
    Eur Heart J; 2007 Feb; 28(3):334-44. PubMed ID: 17251258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
    J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry.
    Daoulah A; Alsheikh-Ali AA; Ocheltree AH; Ocheltree S; Al-Kaabi S; Malik M; Al-Habib AK; Hamed A; Al-Rawahi N; Al-Sayegh A; Al-Hasaniah S; Ul-Haq E
    J Electrocardiol; 2012; 45(3):327-32. PubMed ID: 22074744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term complications of implantable defibrillator therapy in Brugada syndrome.
    Miyazaki S; Uchiyama T; Komatsu Y; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Isobe M; Hirao K; Iesaka Y
    Am J Cardiol; 2013 May; 111(10):1448-51. PubMed ID: 23433764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    Hernandez-Ojeda J; Arbelo E; Borras R; Berne P; Tolosana JM; Gomez-Juanatey A; Berruezo A; Campuzano O; Sarquella-Brugada G; Mont L; Brugada R; Brugada J
    J Am Coll Cardiol; 2017 Oct; 70(16):1991-2002. PubMed ID: 29025556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators.
    Steven D; Roberts-Thomson KC; Inada K; Seiler J; Koplan BA; Tedrow UB; Sweeney MO; Epstein LE; Stevenson WG
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1115-9. PubMed ID: 21545364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of drug-induced Brugada syndrome.
    Sieira J; Ciconte G; Conte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; Saitoh Y; Casado-Arroyo R; Juliá J; La Meir M; Wellens F; Wauters K; Pappaert G; Brugada P
    Heart Rhythm; 2017 Oct; 14(10):1427-1433. PubMed ID: 28479512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
    Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
    Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characterisation and long-term prognosis of women with Brugada syndrome.
    Sieira J; Conte G; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; Saitoh Y; Irfan G; Casado-Arroyo R; Juliá J; La Meir M; Wellens F; Wauters K; Pappaert G; Brugada P
    Heart; 2016 Mar; 102(6):452-8. PubMed ID: 26740482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry.
    Probst V; Veltmann C; Eckardt L; Meregalli PG; Gaita F; Tan HL; Babuty D; Sacher F; Giustetto C; Schulze-Bahr E; Borggrefe M; Haissaguerre M; Mabo P; Le Marec H; Wolpert C; Wilde AA
    Circulation; 2010 Feb; 121(5):635-43. PubMed ID: 20100972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
    Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.